SUSMED,Inc. Income Statement

Financials in millions JPY. Fiscal year is July - June.

Millions JPY. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	497	462	342	530	316
Revenue Growth	7.58%	35.09%	-35.47%	67.72%	174.78%
Cost of Revenue	18	12	12	8	11
Gross Profit	479	450	330	522	305
Selling, General & Admin	562	477	452	394	309
Research & Development	247	273	243	176	226
Operating Expenses	809	750	695	570	535
Operating Income	-330	-300	-365	-48	-230
Other Non Operating Income (Expenses)	4	5	8	4	12
EBT Excluding Unusual Items	-326	-295	-357	-44	-218
Asset Writedown	-67	-4	-2	-5	-15
Other Unusual Items	14	2	3	-	-
Pretax Income	-379	-297	-356	-49	-233
Income Tax Expense	3	1	1	1	-
Net Income	-382	-298	-357	-50	-233
Net Income to Common	-382	-298	-357	-50	-233
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	17	17	17	16	15
Shares Outstanding (Diluted)	17	17	17	16	15
Shares Change	0.33%	0.60%	1.77%	11.71%	14.76%
EPS (Basic)	-22.67	-17.75	-21.39	-3.05	-15.87
EPS (Diluted)	-22.67	-17.75	-21.39	-3.05	-15.87
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-548	-436	-233	94	-177
Free Cash Flow Per Share	-32.52	-25.96	-13.96	5.73	-12.05
Gross Margin	96.38%	97.40%	96.49%	98.49%	96.52%
Operating Margin	-66.40%	-64.94%	-106.73%	-9.06%	-72.78%
Profit Margin	-76.86%	-64.50%	-104.39%	-9.43%	-73.73%
Free Cash Flow Margin	-110.26%	-94.37%	-68.13%	17.74%	-56.01%
EBITDA	-320	-293	-360	-43	-228
EBITDA Margin	-64.39%	-63.42%	-105.26%	-8.11%	-72.15%
D&A For EBITDA	10	7	5	5	2
EBIT	-330	-300	-365	-48	-230
EBIT Margin	-66.40%	-64.94%	-106.73%	-9.06%	-72.78%